Clinical characteristics of 30 children with severe acute SARS‐CoV‐2 infection

Clinical characteristics of 30 children with severe acute SARS‐CoV‐2 infection

Abstract Background To describe the characteristics of pediatric patients with severe COVID‐19 in China and identify the clinical variables associated with cardiovascular involvement, severe neurological complications, and disease prognosis. Methods A retrospective surveillance study were conducted...

Full description

Saved in:

Bibliographic Details
Main Authors:	Weijun Li, Danping Zhu, Weiqiang Xiao, Defeng Liang, Huarong Deng, Jipeng Zheng, Qiang Wang, Guangming Liu, Peiqing Li
Format:	Article
Language:	English
Published:	Wiley 2024-12-01
Series:	Hong Kong Journal of Emergency Medicine
Subjects:	child COVID‐19 neurological involvement SARS‐CoV‐2 shock
Online Access:	https://doi.org/10.1002/hkj2.12043
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

SARS-CoV-2 Trasmission and Outcome in Neuro-rehabilitation patients hospitalized at Neuroscience Hospital in Italy
by: Francesco Di Gennaro
Published: (2020-08-01)

Cross-Section of Neurological Manifestations Among SARS-CoV-2 Omicron Subvariants—Single-Center Study
by: Justyna Jachman-Kapułka, et al.
Published: (2024-11-01)

Is The SARS-CoV2 Evolved in Human Being: A prospective Genetic Analysis
by: Salvatore Dimonte, et al.
Published: (2020-12-01)

Neurodevelopment in the first year of children exposed to SARS-CoV-2 during intrauterine period: systematic review
by: Aline Helena Nascimento Veloso, et al.
Published: (2024-11-01)

Sustained applicability of SARS-CoV-2 variants identification by Sanger Sequencing Strategy on emerging various SARS-CoV-2 Omicron variants in Hiroshima, Japan
by: Chanroth Chhoung, et al.
Published: (2024-11-01)

Impact of SARS-CoV-2 variants on COVID-19 symptomatology and severity during five waves
by: Bruno Belmonte Martinelli Gomes, et al.
Published: (2024-11-01)

Exosomes and SARS-CoV-2 infection
by: Liuying Li, et al.
Published: (2024-11-01)

Genomic Diversity and Evolution of Identified SARS-CoV-2 Variants in Iraq
by: Ahmed A. Al-Mankhee, et al.
Published: (2024-11-01)

Vaccination caused an underestimation of the cumulative incidence of SARS-CoV-2 infection
by: Nana Owusu-Boaitey
Published: (2025-02-01)

Broad‐Spectrum Engineered Multivalent Nanobodies Against SARS‐CoV‐1/2
by: Zhihong Wang, et al.
Published: (2024-12-01)

Current Updates on Variants of SARS‐CoV‐ 2: Systematic Review
by: Mulat Erkihun, et al.
Published: (2024-11-01)

Accurate predictions of SARS-CoV-2 infectivity from comprehensive analysis
by: Jongkeun Park, et al.
Published: (2024-12-01)

Unraveling the SARS-CoV-2 spike protein long-term effect on neuro-PASC
by: Filipe Menezes, et al.
Published: (2024-12-01)

Delivery in asymptomatic Italian woman with SARS-CoV-2 infection.
by: Giuseppe Vittorio De Socio, et al.
Published: (2020-04-01)

The effect of SARS-CoV-2 Omicron BA. 5.2 infection on perioperative physiological indicators in orthopedic patients
by: Hao Wu, et al.
Published: (2025-01-01)

A Possible Protective Effect of IgA Against Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) in Bronchoalveolar Lavage in COVID-19 Patients Admitted to Intensive Care Unit
by: Mariantonietta Di Stefano, et al.
Published: (2024-11-01)

Placental Infection with Different SARS-CoV-2 Variants Leading to Stillbirth: Report of Two Cases
by: Miriam A. Snow, et al.
Published: (2025-01-01)

Genomic epidemiology of early SARS-CoV-2 transmission dynamics in Bangladesh
by: L. Carnegie, et al.
Published: (2024-11-01)

Administration of Lactobacillus plantarum GUANKE alleviates SARS-CoV-2-induced pneumonia in mice
by: He Huang, et al.
Published: (2024-12-01)

Neurological side effects of SARS-CoV-2 vaccination are common and can be severe
by: Josef Finsterer
Published: (2025-02-01)

Genomic and epidemiological analysis of SARS-CoV-2 variants isolated in Guinea: a routine sequencing implementation
by: Aminata Mbaye, et al.
Published: (2025-01-01)

Respiratory viruses and SARS-CoV-2 virus circulation in the provinces of Lucca and Massa Carrara during the 2022/2023 and 2023/2024 flu seasons
by: Veronica Cunsolo, et al.
Published: (2024-11-01)

Reply to “Vaccination caused underestimation of cumulative incidence of SARS-CoV-2 infection”
by: Jefferson M. Jones, et al.
Published: (2025-02-01)

Airborne SARS-CoV-2 RNA detected during deliveries with unmasked patients
by: Sara Thuresson, et al.
Published: (2024-12-01)

Seroprevalence of anti SARS-CoV2 antibodies in Umbrian persons living with HIV
by: chiara papalini, et al.
Published: (2020-10-01)

SARS-CoV-2 serologic surveillance among people living with HIV in Nigeria, April 2022 to January 2023
by: Helen M. Chun, et al.
Published: (2025-02-01)

Obtaining patient phenotypes in SARS-CoV-2 pneumonia, and their association with clinical severity and mortality
by: Fernando García-García, et al.
Published: (2024-06-01)

Assessment of Favipiravir and Remdesivir in Combination for SARS-CoV-2 Infection in Syrian Golden Hamsters
by: Megan Neary, et al.
Published: (2024-11-01)

Serological insights from SARS-CoV-2 heterologous prime and boost responses in Thailand
by: Daniel Ward, et al.
Published: (2025-01-01)

Seroprevalence of SARS-CoV-2 Infection Among People Living with HIV in Libreville, Gabon
by: Samira Zoa-Assoumou, et al.
Published: (2024-12-01)

Dynamics of cytokine and antibody responses in community versus hospital SARS-CoV-2 infections
by: Tulika Singh, et al.
Published: (2024-11-01)

Corrigendum: Identifying risk factors for secondary infection post-SARS-COV-2 infection in patients with severe and critical COVID-19
by: Mingquan Guo, et al.
Published: (2025-01-01)

Identifying Risk Factors for Secondary Infection Post-SARS-CoV-2 Infection in Patients With Severe and Critical COVID-19
by: Mingquan Guo, et al.
Published: (2021-09-01)

SARS-CoV-2 Assembly: Gaining Infectivity and Beyond
by: Harshita Katiyar, et al.
Published: (2024-10-01)

Strategies Used by SARS-CoV-2 to Evade the Innate Immune System in an Evolutionary Perspective
by: Hong Fan, et al.
Published: (2024-12-01)

Development of potent and effective SARS-CoV-2 main protease inhibitors based on maleimide analogs for the potential treatment of COVID-19
by: Karol Biernacki, et al.
Published: (2024-12-01)

Seroprevalence against SARS-CoV-2 after booster vaccination in a prison in Alicante (Spain)
by: Ana C. Montagud, et al.
Published: (2025-01-01)

Impact of emergency financial support program on testing demand, SARS-CoV-2 prevalence, and social isolation during COVID-19 outbreak in Brazil: a quasi-experimental study
by: Gabriel Alves de Sampaio Morais, et al.
Published: (2024-12-01)

Histological Findings of Resected Tracheal Ring in SARS-CoV-2-Positive and -Negative Tracheostomized Patients
by: Nieves Mata-Castro, et al.
Published: (2024-12-01)

Histoplasmosis e infección por SARS-CoV-2 en un paciente críticamente enfermo
by: Isasio Serna, et al.
Published: (2023-01-01)